Dn B Asset Management As Novavax Inc Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022
SELL
$36.28 - $75.29 $376,695 - $781,736
-10,383 Closed
0 $0
Q1 2022

Apr 08, 2022
BUY
$69.73 - $142.9 $17,920 - $36,725
257 Added 2.54%
10,383 $764,000
Q4 2021

Jan 12, 2022
BUY
$134.56 - $217.97 $1.36 Million - $2.21 Million
10,126 New
10,126 $1.45 Million

Others Institutions Holding NVAX

# of Institutions
284
Shares Held
83.2M
Call Options Held
5.43M
Put Options Held
9M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $910M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email